Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2025-12-27 @ 5:33 PM
Study NCT ID:
NCT04547504
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-17
First Post:
2020-08-31
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %
Sponsor:
University Hospital, Brest
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-12-22
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-22
Completion Date Type:
ESTIMATED
First Submit Date:
2020-08-31
First Submit QC Date:
None
Study First Post Date:
2020-09-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-16
Last Update Post Date:
2025-09-17
Last Update Post Date Type:
ESTIMATED